Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP

This study aims to investigate whether neutrophil to lymphocyte ratio (NLR) is an independent predictor in newly diagnosed diffuse large B-cell lymphoma (DLBCL) patients in the rituximab era. Data from newly diagnosed DLBCL patients at Nanjing Drum Tower Hospital from 2006 to 2015 were retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Zhou, Min, Xu, Jing-Yan, Yang, Yong-Gong, Zhang, Qi-Guo, Zhou, Rong-Fu, Chen, Bing, Ouyang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044903/
https://www.ncbi.nlm.nih.gov/pubmed/27661033
http://dx.doi.org/10.1097/MD.0000000000004893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044903/
https://www.ncbi.nlm.nih.gov/pubmed/27661033
http://dx.doi.org/10.1097/MD.0000000000004893

Ejemplares similares